Semantic Networks in Alcohol Use Disorder Patients: Exploratory Study
ALCOOLNET
2 other identifiers
observational
41
1 country
1
Brief Summary
Alcohol Use Disorder (AUD) is a major public health problem, characterized by a high rate of relapse. Chronic and excessive alcohol consumption notably induces frontal brain alterations and cognitive impairments such as executive dysfunction and an attentional bias for alcohol, participating to the risk of relapse. In effect, AUD patients preferentially process alcohol-related cues, which could reflect a reorganization of the patients' semantic network. The investigators hypothesize that in AUD patients, semantic associations in memory are reorganized with a higher centrality of alcohol-related elements. To the investigators knowledge, no studies have explored semantic associations and/or semantic networks in AUD. A study, conducted in patients with neurological damage, showed that frontal lesions are associated with excessive strength in semantic associations, and difficulties to generate remote associations. This excessive strength in semantic associations could reduce the ability to inhibit automatisms and to adapt to new context. Objective: The objective of this study is to explore whether and how AUD patients have a different organization of semantic associations than healthy controls, and whether this reorganization influences the alcohol consumption over the months following the withdrawal. The investigators will also explore how it relates to neuropsychological assessment of flexibility, executive functions, and impulsivity. To these purposes, the investigators will use two original verbal tasks (Free Generation of Associates Task, FGAT and Associative Judgment Task, AJT) assessing word associations and allowing the estimation of semantic networks using graph theory, in combination with neuropsychological testing, in AUD patients and in healthy controls. Methods: This study will include a group of 30 AUD patients and a group of 30 healthy controls. Both groups will be assessed twice, at baseline (T1; early in abstinence for AUD patients) and after a three-month period (T3). For the two groups, T1 and T3 assessments will include the two semantic association tasks (FGAT and AJT). For AUD patients, assessments will also involve neuropsychological testing of impulsivity, flexibility, and attentional bias. Besides, in AUD patients, data about alcohol consumptions will be collected six weeks (T2) and three months (T3) following the baseline assessment to classify patients as relapsers or abstainers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 3, 2022
CompletedFirst Posted
Study publicly available on registry
December 5, 2022
CompletedStudy Start
First participant enrolled
April 19, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 7, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 7, 2025
CompletedApril 27, 2026
April 1, 2026
2.5 years
November 3, 2022
April 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Description of the semantic associations using FGAT
The Free Generation Associated Tasks will be used in Alcohol use disorder patients and Healthy controls
At baseline (T1)
Description of the semantic associations using AJT
The Associative Judgment Task will be used in Alcohol use disorder patients and Healthy controls
At baseline (T1)
Secondary Outcomes (16)
Impact of medications on the semantic association performance
At baseline (T1)
Impact of age on the semantic association performance
At baseline (T1)
Impact of the study level on the semantic association performance
At baseline (T1)
Impact of gender on the semantic association performance
At baseline (T1)
Impact of the duration of dependence on the semantic association performance
At baseline (T1)
- +11 more secondary outcomes
Study Arms (2)
Alcohol use disorder patients
Healthy controls
Eligibility Criteria
Two groups of participants will be included in this study. The first one consists of a pool of alcohol use disorder, the second one consists of a pool of healthy controls ; they will be matched as much as possible on age, gender, and educational level.
You may qualify if:
- For alcohol use disorder patients
- Severe alcohol use disorder
- French as mother tongue
- Right-hander
- Patient who gave his informed written consent
- Currently in outpatient or inpatient care
- For healthy controls
- French as mother tongue
- Right-hander
- Participant who gave his informed written consent
You may not qualify if:
- For alcohol use disorder patients
- Patient under guardianship or under justice safeguard measures
- Patient under measure of therapeutic injunction
- Pregnancy or breastfeeding declared
- Meeting Diagnostic and Statistical Manual 5 (DSM) criteria for substance use disorder other than Tobacco
- Meeting DSM-5 criteria for non substance use disorder
- Patient presenting severe or progressive disease that interfere with experimental tasks, such as neurological diseases (TBI, epilepsy, stoke) , hepatic diseases, cancer, HIV, Hepatitis C Virus (HCV), and unstable psychiatric comorbidities.
- For healthy controls
- Participant under guardianship or under justice safeguard measures
- Participant under measure of therapeutic injunction
- Pregnancy or breastfeeding declared
- Meeting DSM-5 criteria for alcohol use disorder
- Meeting DSM-5 criteria for substance use disorder other than Tobacco
- Meeting DSM-5 criteria for non substance use disorder
- Currently under benzodiazepine
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fernand Widal Hospital
Paris, Île-de-France Region, 75010, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alexandra Dereux, PH (MD)
APHP
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 3, 2022
First Posted
December 5, 2022
Study Start
April 19, 2023
Primary Completion
October 7, 2025
Study Completion
October 7, 2025
Last Updated
April 27, 2026
Record last verified: 2026-04